Long - term outcomes after the fontan surgery in patients with congenital heart disease and single - ventricle physiology at the Cardiovascular Center of E Hospital
Main Article Content
Abstract
Objective: To evaluate long - term outcomes and identify risk factors for late complications after the Fontan procedure in patients with single - ventricle physiology. Methods: A cross - sectional descriptive study was conducted on 90 patients who underwent Fontan procedure at E Hospital between 2011 and 2019 and were invited for follow - up examinations from July to October 2025. Results: Mean follow - up duration was 9.1 ± 2.0 years. Freedom from rehospitalization was 72.2%, and 86.7% required no reintervention; Late complications included protein - losing enteropathy (PLE) (11.1%), liver disease (36.7%), arrhythmia (4.4%), atrioventricular valve dysfunction (24,4%), and Fontan obstruction (3.3%). Independent risk factors for occurrence of PLE: follow - up ≥ 8 years (OR = 3.40), EF < 55% (OR = 4.95), hepatic venous reflux (OR = 3.75). Arrhythmia: follow-up ≥ 8 years (OR = 3.95), moderate AV valve regurgitation (OR = 4.85), Fontan flow reflux (OR = 3.45). Conclusions: The Fontan procedure provides favorable long - term outcomes; however, late complications remain significant. Lifelong surveillance is essential for optimal management.
Keywords
Fontan, single ventricle, long-term outcomes, protein-losing enteropathy, Fontan-associated liver disease
Article Details
References
2. Deal BJ, Jacobs ML. Management of the failing Fontan circulation. Heart. 2012 Jul 15;98(14):1098–104. doi:10.1136/heartjnl-2011-301133 PubMed PMID: 22739639; PubMed Central PMCID: PMC3386650.
3. Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K, et al. The Precarious State of the Liver After a Fontan Operation: Summary of a Multidisciplinary Symposium. Pediatr Cardiol. 2012;33(7):1001–12. doi:10.1007/s00246-012-0315-7 PubMed PMID: 22534759; PubMed Central PMCID: PMC3442163.
4. d’Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR, et al. Redefining Expectations of Long-Term Survival After the Fontan Procedure. Circulation. 2014 Sep 9;130(11_suppl_1):S32–8. doi:10.1161/CIRCULATIONAHA.113.007764
5. TRẦN ĐẮC ĐẠI. NGHIÊN CỨU KẾT QUẢ PHẪU THUẬT FONTAN TRONG ĐIỀU TRỊ BỆNH NHÂN TIM BẨM SINH CÓ SINH LÝ TUẦN HOÀN MỘT THẤT. 2021.
6. Mayer JE, Bridges ND, Lock JE, Hanley FL, Jonas RA, Castaneda AR. Factors associated with marked reduction in mortality for Fontan operations in patients with single ventricle. The Journal of Thoracic and Cardiovascular Surgery. 1992 Mar 1;103(3):444–52. doi:10.1016/S0022-5223(19)34983-9
7. Burch PT, Gerstenberger E, Ravishankar C, Hehir DA, Davies RR, Colan SD, et al. Longitudinal Assessment of Growth in Hypoplastic Left Heart Syndrome: Results From the Single Ventricle Reconstruction Trial. Journal of the American Heart Association. 2014 May 22;3(3):e000079. doi:10.1161/JAHA.114.000079
8. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: An international multicenter study. The Journal of Thoracic and Cardiovascular Surgery. 1998 May 1;115(5):1063–73. doi:10.1016/S0022-5223(98)70406-4
9. Barracano R, Merola A, Fusco F, Scognamiglio G, Sarubbi B. Protein-losing enteropathy in Fontan circulation: Pathophysiology, outcome and treatment options of a complex condition. International Journal of Cardiology Congenital Heart Disease. 2022 Mar 1;7:100322. doi:10.1016/j.ijcchd.2022.100322
10. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology. 1996 Dec 1;49(12):1373–9. doi:10.1016/S0895-4356(96)00236-3